The effect of CDK4 inhibitor to AML

被引：0
|
作者：
wang, Jie [1 ]
机构：
[1] Ohio State Univ, Dept Pharmacol, Columbus, OH 43210 USA
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] The effect of CDK4 inhibitor to AML
    Wang, Jie
    Briesewitz, Roger
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 115 - 115
  • [2] TARGETED COMBINATION THERAPY WITH CDK4/6 INHIBITOR PALBOCICLIB IN AML
    Uras, I.
    Valent, P.
    Sexl, V.
    HAEMATOLOGICA, 2017, 102 : 207 - 208
  • [3] The CDK4/6 Inhibitor Palbociclib Synergizes with ATRA to Induce Differentiation in AML
    Hu, Linhui
    Li, Qian
    Wang, Jiyu
    Wang, Huiping
    Ren, Xiyang
    Huang, Keke
    Wang, Yangyang
    Liang, Xue
    Pu, Lianfang
    Xiong, Shudao
    Zhai, Zhimin
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (07) : 961 - 972
  • [4] Inducible deletion of CDK4 and CDK6-deciphering CDK4/6 inhibitor effects in the hematopoietic system
    Maurer, Barbara
    Brandstoetter, Tania
    Kollmann, Sebastian
    Sexl, Veronika
    Prchal-Murphy, Michaela
    HAEMATOLOGICA, 2021, 106 (10) : 2624 - 2632
  • [5] Biomarkers for CDK4/6 inhibitor efficacy
    Sorscher, Steven
    BREAST JOURNAL, 2021, 27 (01): : 103 - 103
  • [6] Development and characterization of a novel CDK4/6 inhibitor for the treatment of CDK4/6 dependent cancers
    O'Brien, Neil A.
    McDermott, Martina S.
    O'Boyle, Brendan M.
    Hilf, Justin A.
    Loson, Oliver
    Chau, Kevin
    Jia, Weiping
    Kamranpour, Naeimeh
    Luo, Tong
    Ayala, Raul
    Issakhanian, Shawnt
    Glaspy, John A.
    Stoltz, Brian M.
    Slamon, Dennis J.
    CANCER RESEARCH, 2023, 83 (07)
  • [7] PALBOCICLIB Cyclin CDK4/CDK6 Inhibitor Oncolytic
    Haddley, K.
    DRUGS OF THE FUTURE, 2013, 38 (11) : 745 - 755
  • [8] The identification of combinations for the CDK4 and CDK6 inhibitor, abemaciclib
    Gong Xueqian
    Chio, Li-Chun
    Webster, Yue
    Lallena, Maria Jose
    Boehnke, Karsten
    Torres, Raquel
    Iversen, Phil
    De Dios, Alfonso
    Smith, Ian
    Reinhard, Christoph
    Peng, Sheng-Bin
    Dempsey, Jack
    Burke, Teresa
    Chen, Shih-Hsun
    Stewart, Trent
    Beckmann, Richard
    Wu, Wenjuan
    Buchanan, Sean G.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [9] Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs
    Green, Jennifer L.
    Okerberg, Eric S.
    Sejd, Josilyn
    Palafox, Marta
    Monserrat, Laia
    Alemayehu, Senait
    Wu, Jiangyue
    Sykes, Maria
    Aban, Arwin
    Serra, Violeta
    Nomanbhoy, Tyzoon
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) : 771 - 779
  • [10] Lysosome-targeted cytocidal effect of CDK4/6 inhibitor abemaciclib
    Hino, Hirotsugu
    Kazama, Hiromi
    Moriya, Shota
    Takano, Naoharu
    Hiramoto, Masaki
    Miyazawa, Keisuke
    CANCER SCIENCE, 2018, 109 : 1026 - 1026
12345